| Business Type | Exporter, Supplier, Retailer |
| Packaging | Box |
| Color | White |
| Type | Anti Cancer Medicines |
| Click to view more | |
Product Details
Form
Tablets
Packaging Size
60 Tablets in One Box
Usage
Treatment Of Certain Types Of HER2-positive Breast Cancer
Dosage
150 Mg
Targeted Therapy
Yes
Primary Use
Treatment Of Advanced Or Metastatic Breast Cancer
Additional Info
Selective HER2 Tyrosine Kinase Inhibitor
LuciTuca 150mg contains Tucatinib, a targeted therapy used primarily in the treatment of certain types of HER2-positive breast cancer. It represents a significant advancement in oncology, particularly in managing advanced or metastatic breast cancer that has spread beyond the breast, including to the brain. Tucatinib, developed as a selective HER2 tyrosine kinase inhibitor, is a valuable tool in the evolving landscape of personalized cancer therapy
Looking for "Tucatinib 150 Mg Tablet" ?
Pack
